939426-84-3

Usage

Uses

Used in Scientific Research:
(3-Hydroxy-cyclopentyl)-carbamic acid benzyl ester is used as a research compound for its unique structural features and potential applications in various scientific fields. Its carbamic acid derivative nature allows for exploration of its chemical properties and interactions with other compounds, making it a valuable tool in the development of new materials and pharmaceuticals.
Used in Pharmaceutical Development:
(3-Hydroxy-cyclopentyl)-carbamic acid benzyl ester is used as a potential pharmaceutical candidate due to its carbamic acid derivative nature. Its unique structure may offer new opportunities for drug design and development, particularly in the areas of medicinal chemistry and drug discovery. Further research is needed to fully understand its therapeutic potential and possible applications in treating various diseases and conditions.
Used in Material Science:
(3-Hydroxy-cyclopentyl)-carbamic acid benzyl ester is used as a component in the development of new materials, leveraging its cyclopentanol structure and carbamic acid derivative properties. Its potential applications in material science may include the creation of novel polymers, coatings, or other advanced materials with unique properties and improved performance.

Upstream product

• 946593-67-5 (1S,3S)-3-aminocyclopentan-1-ol 
• 75315-63-8 N-(benzyloxycarbonyl)succinimide 
• 124555-33-5 (trans)-3-aminocyclopentan-1-ol hydrochloride 
• 501-53-1 benzyl chloroformate 
• 167298-58-0 (±)-trans-(3-hydroxy-cyclopentyl)amine 
• 1184919-69-4 rac-3-aminocyclopentanol hydrochloride 

Downstream Products

• 932706-26-8 benzyl [(1S,3R)-3-fluorocyclopentyl]carbamate 
• 939525-61-8 3,3-difluorocyclopentanamine 

Relevant academic research and scientific papers

HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS

Heterocyclic compounds as CDK4 or CDK6 or other CDK inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.

Novel Imidazo[4,5-c]Quinoline And Imidazo[4,5-c][1,5]Naphthyridine Derivatives As LRRK2 Inhibitors

The present invention provides novel imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives of Formula (I), and the pharmaceutically acceptable salts thereof wherein R1, R1a, R1b, R2, R4, R5, R6, X and Z are as defined in the specification. The invention is also directed to pharmaceutical compositions comprising the compounds of Formula (I) and to use of the compounds in the treatment of diseases associated with LRRK2, such as neurodegenerative diseases including Parkinson's disease or Alzheimer's disease, cancer, Crohn's disease or leprosy.

TETRACYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS

The present invention relates to Tetracyclic Heterocycle Compounds of Formula (I) and pharmaceutically acceptable salts or prodrug thereof, wherein n, X, Y, Z, R1, R2, and R3 are as defined herein. The present invention also relates to compositions comprising at least one Tetracyclic Heterocycle Compound, and methods of using the Tetracyclic Heterocycle Compounds for treating or preventing HIV infection in a subject.

ARYL-SUBSTITUTED NITROGEN-CONTAINING HETEROCYCLIC COMPOUND

Disclosed is an aryl-substituted nitrogen-containing heterocyclic compound represented by the formula (I) below or a pharmaceutically acceptable salt thereof. This compound serves as a nociceptin receptor antagonist and is useful as a pharmaceutical agent for treating diseases associated with a nociceptin receptor. (I) [In the formula, A1, A2 and A3 independently represent a carbon atom or a nitrogen atom, and one or two of A1, A2 and A3 represent a carbon atom; R1 represents a lower alkyl group or the like; R2 represents a phenyl group which may be substituted by a halogen atom or the like; R3 represents a hydrogen atom, a lower alkyl group or the like; and R4 represents a lower alkyl group or the like.]

4-CYCLOALKYLAMINOPYRAZOLO PYRIMIDINE NMDA/NR2B ANTAGONISTS

Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof, are effective as NMDA/NR2B antagonists useful for treating neurological conditions such as, for example, pain, Parkinson's disease, Alzheimer's disease, epilepsy, depression, anxiety, ischemic brain injury including stroke, and other conditions.